A very low incidence of BRAF mutations in Middle Eastern colorectal carcinoma

BACKGROUND: Recent studies emphasize the role of BRAF as a genetic marker for prediction, prognosis and risk stratification in colorectal cancer. Earlier studies have reported the incidence of BRAF mutations in the range of 5-20% in colorectal carcinomas (CRC) and are predominantly seen in the serra...

Descripción completa

Detalles Bibliográficos
Autores principales: Siraj, Abdul K, Bu, Rong, Prabhakaran, Sarita, Bavi, Prashant, Beg, Shaham, Al Hazmi, Mohsen, Al-Rasheed, Maha, Alobaisi, Khadija, Al-Dayel, Fouad, AlManea, Hadeel, Al-Sanea, Nasser, Uddin, Shahab, Al-Kuraya, Khawla S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4109832/
https://www.ncbi.nlm.nih.gov/pubmed/25005754
http://dx.doi.org/10.1186/1476-4598-13-168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4109832/
https://www.ncbi.nlm.nih.gov/pubmed/25005754
http://dx.doi.org/10.1186/1476-4598-13-168

Ejemplares similares